Clinical Nephrotoxins

- General
- Clinical relevance
- Drug-associated acute kidney injury in the intensive care unit
- Renal handling of drugs and xenobiotics
- Pharmacological aspects of nephrotoxicity
- Pharmacovigilance: from signal to action
- Urinary biomarkers and nephrotoxicity
- Toxin-induced immunological renal disease
- Cellular mechanisms of nephrotoxicity
- Animal models for the assessment of acute renal dysfunction and injury
- Renal cell culture models: Contribution to the understanding of nephrotoxic mechanisms
- Use of dialytic therapies for poisoning
- Specific Drugs
- Aminoglycosides and vancomycin
- Beta-lactam antibiotics
- Amphotericin B
- Sulfonamides, sulfadiazine, trimethoprim-sulfamethoxazole, pentamidine, pyrimethamine, dapsone, quinolones
- Antiviral agents
- Analgesics and 5-aminosalicylic acid
- Non-steroidal anti-inflammatory drugs
- Gold salts, D-penicillamine and allopurinol
- Angiotensin I convert ing enzyme inhibitors and angiotensin II receptor antagonists
- Diuretics and alcohol ingestion
- Anticancer drugs
- Anesthetic agents
- Bisphosphonates and the kidney
- Proton pump inhibitors: acute interstitial nephritis and other renal effects
- Oral sodium phosphate bowel purgatives and acute phosphate nephropathy
- Illicit drug abuse and renal disease
- Nephrotoxicity of calcineurin and mTOR inhibitors
- Immunomodulators: interleukins, interferons, and IV immunoglobulin
- Imaging agents
- Lithium-associated kidney effects
- Oxalate
- Herbal remedies containing aristolochic acid and mushroom nephrotoxicity
- Environmental and Occupational Nephrotoxins
- Lead nephropathy
- Cadmium-induced renal effects
- Mercury-induced renal effects
- Organic solvents, silicon-containing compounds and pesticides
- Balkan nephropathy
- Nephrotoxins in Africa
- Paraphenylene diamine hair dye poisoning
- The Renal Failure Patient
- Trace metal disturbances in end-stage renal failure patients
- Smoking and the kidney
- Star fruit
-

From the reviews of the third edition: